Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
3.110
-0.100 (-3.12%)
Sep 18, 2024, 4:00 PM EDT - Market closed
Envoy Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.3 | 0.32 | 0.24 | 0.31 |
| Revenue Growth (YoY) | 38.53% | 33.33% | -23.55% | - |
| Cost of Revenue | 0.85 | 0.79 | 0.5 | 0.77 |
| Gross Profit | -0.55 | -0.47 | -0.26 | -0.46 |
| Selling, General & Admin | 9.5 | 8.94 | 3.47 | 2.47 |
| Research & Development | 9.83 | 8.96 | 4.98 | 3.94 |
| Operating Expenses | 19.33 | 17.9 | 8.45 | 6.41 |
| Operating Income | -19.88 | -18.37 | -8.71 | -6.87 |
| Other Non Operating Income (Expenses) | 19.75 | 1.8 | -0.13 | -1.8 |
| EBT Excluding Unusual Items | -0.29 | -16.58 | -8.83 | -8.67 |
| Gain (Loss) on Sale of Assets | - | - | - | -0 |
| Other Unusual Items | -13.33 | -13.33 | -7.09 | - |
| Pretax Income | -13.63 | -29.91 | -15.92 | -8.68 |
| Net Income | -13.63 | -29.91 | -15.92 | -8.68 |
| Net Income to Common | -16.36 | -29.91 | -15.92 | -8.68 |
| Shares Outstanding (Basic) | 17 | 13 | 10 | 10 |
| Shares Outstanding (Diluted) | 17 | 13 | 10 | 10 |
| Shares Change (YoY) | -87.57% | 24.00% | -0.04% | - |
| EPS (Basic) | -0.95 | -2.38 | -1.57 | -0.86 |
| EPS (Diluted) | -0.95 | -2.38 | -1.57 | -0.86 |
| Free Cash Flow | -21.8 | -17.81 | -9.02 | -7.06 |
| Free Cash Flow Per Share | -1.26 | -1.42 | -0.89 | -0.70 |
| Gross Margin | -181.46% | -149.68% | -110.13% | -148.06% |
| Operating Margin | -6582.12% | -5813.61% | -3673.42% | -2216.45% |
| Profit Margin | -5415.89% | -9464.56% | -6718.57% | -2798.39% |
| Free Cash Flow Margin | -7219.54% | -5635.13% | -3807.17% | -2277.74% |
| EBITDA | -19.73 | -18.24 | -8.63 | -6.8 |
| D&A For EBITDA | 0.15 | 0.13 | 0.08 | 0.07 |
| EBIT | -19.88 | -18.37 | -8.71 | -6.87 |
Source: S&P Capital IQ. Standard template.
Financial Sources.